Effects of chewing betel nut (Areca catechu) on the symptoms of people with schizophrenia in Palau, Micronesia
Open Access
- 1 August 2000
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 177 (2), 174-178
- https://doi.org/10.1192/bjp.177.2.174
Abstract
Background: Although millions of people with schizophrenia live in betel chewing regions, the effects of betel chewing on their symptoms are unknown. Betel nut alkaloids include potent muscarinic cholinomimetics: recent research suggests that these agents may be therapeutic in schizophrenia.Aims: To compare the primary and extrapyramidal symptom profiles and substance-using habits of betel chewing v. non-chewing people with schizophrenia.Method: A cross-sectional study of 70 people with schizophrenia. Symptom ratings measured by the Positive and Negative Syndrome Scale (PANSS) and Extrapyramidal Symptom Rating Scale (ESRS), and demographic and substance-use data, were compared for 40 chewers and 30 non-chewers of betel nut.Results: Betel chewers with schizophrenia scored significantly lower on the positive (P=0.001) and negative (P=0.002) sub-scales of the PANSS than did non-chewers. There were no significant differences in extrapyramidal symptoms or tardive dyskinesia.Conclusions: Betel chewing is associated with milder symptomatology and avoidance of more harmful recreational drugs. These initial results indicate that longitudinal research is merited.Keywords
This publication has 14 references indexed in Scilit:
- Muscarinic agents: A new approach to the treatment of psychosisSchizophrenia Research, 1998
- Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease*Clinical Pharmacology & Therapeutics, 1996
- Smoking among Chinese Patients with SchizophreniaAustralian & New Zealand Journal of Psychiatry, 1996
- Gender Differences in Tardive Dyskinesia: A Critical Review of the LiteratureSchizophrenia Bulletin, 1992
- Cholinergic Hyperactivity and Negative Schizophrenic SymptomsArchives of General Psychiatry, 1989
- Betel nut‐induced extrapyramidal syndrome: An unusual drug interactionMovement Disorders, 1989
- SINGLE CASE STUDYThe Journal of Nervous and Mental Disease, 1979
- Cholinergic involvement in mental disordersLife Sciences, 1978
- On diagnostic classificationAmerican Journal of Psychiatry, 1977
- Betel nut as a GABA blockerAmerican Journal of Psychiatry, 1977